1 completed, 1 terminated. 2 Phase 1.
| Phase | Trials | Status |
|---|---|---|
| Phase 1 | 2 | Completed 1, Terminated 1 |
Follow Prokidney: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| A Study of Participants With Chronic Kidney Disease Previously Treated With REACT Renal Autologous Cell Therapy (REACT) - Diabetic Kidney Disease, CAKUT | Phase 1 | Terminated | Prokidney | 1 | 2023-07-11 | 2025-02-28 |
| A Study of a Renal Autologous Cell Therapy (REACT) in Patients With Chronic Kidney Disease (CKD) From Congenital Anomalies of the Kidney and Urinary Tract (CAKUT). Renal Autologous Cell Therapy (REACT) - Chronic Kidney Disease, Congenital Anomalies of Kidney and Urinary Tract | Phase 1 | Completed | Prokidney | 6 | 2019-08-13 | 2023-12-21 |
Cakut (2) · Renal Insufficiency, Chronic (2) · Diabetic Nephropathies (1)
United States (2)